Skip to content

Clinical trials

Connective Tissue Diseases trials in Bulgaria

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Connective Tissue Diseases Country / region: Bulgaria Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20102
20131
20161
20181
20193
20201
20223
20233
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Active, not recruiting4
Enrolling by invitation3
Terminated2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Viatris Innovation GmbH3
Bristol-Myers Squibb2
UCB Pharma2
United Therapeutics2
Alumis Inc1
Amgen1
AstraZeneca1
Biogen1
Eli Lilly and Company1
Lakefront Biotherapeutics NV1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Connective Tissue Diseases16
Immune System Diseases12
Autoimmune Diseases10
Lupus Erythematosus, Systemic10
Skin and Connective Tissue Diseases3
Arthritis2
Cardiovascular Diseases2
Familial Primary Pulmonary Hypertension2
Hypertension2
Hypertension, Pulmonary2

Trials

Showing 51 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.